The companies are working together to make it easier for companies to offer health plans that include these medications.

A study by GNC suggests that GLP-1s users are risking malnourishment and muscle loss. GNC announced the results of a study ...

With acquisition of Verve Therapeutics, Eli Lilly aims to advance next-generation cardiovascular care through one-time gene ...

Andembry is the first prophylactic therapy for hereditary angioedema to target factor XIIa, inhibiting the top of the ...

Transformation in healthcare is ongoing and purpose-driven. It’s not a fleeting trend but a continuous process rooted in ...